Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Key publications

Krones E, Eller K, Pollheimer MJ, Racedo S, Kirsch AH, Frauscher B, Wahlström A, Ståhlman M, Trauner M, Grahammer F, Huber TB, Wagner K, Rosenkranz AR, Marschall HU, Fickert P.
NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
J Hepatol doi: 10.1016/j.jhep.2017.02.019 (2017).

Wahlström A, Kovatcheva-Datchary P, Ståhlman M, Khan MT, Bäckhed F, Marschall HU.
Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.
J Lipid Res. 58:412-419 (2017).

Fuchs CD, Paumgartner G, Wahlström A, Schwabl P, Reiberger T, Leditznig N, Stojakovic T, Rohr-Udilova N, Chiba P, Marschall HU, Trauner M.
Metabolic preconditioning protects BSEP/ABCB11(-/-) mice against cholestatic liver injury.
J Hepatol. 66:95-101 (2017).

Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D; POISE Study Group.
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
N Engl J Med. 375:631-43 (2016).

Wahlström A, Sayin SI, Marschall HU, Bäckhed F.
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.
Cell Metab. 24:41-50 (2016).

Kummen M, Holm K, Anmarkrud JA, Nygård S, Vesterhus M, Høivik ML, Trøseid M, Marschall HU, Schrumpf E, Moum B, Røsjø H, Aukrust P, Karlsen TH, Hov JR.
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Gut. doi: 10.1136/gutjnl-2015-310500 (2016).

Baghdasaryan A, Fuchs CD, Österreicher CH, Lemberger UJ, Halilbasic E, Påhlman I, Graffner H, Krones E, Fickert P, Wahlström A, Ståhlman M, Paumgartner G, Marschall HU, Trauner M.
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
J Hepatol. 64:674-81 (2016).

Graffner H, Gillberg PG, Rikner L, Marschall HU.
The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation.
Aliment Pharmacol Ther. 43:303-10 (2016).

Wikström Shemer EA, Stephansson O, Thuresson M, Thorsell M, Ludvigsson JF, Marschall HU.
Intrahepatic cholestasis of pregnancy and cancer, immune-mediated
and cardiovascular diseases: A population-based cohort study.

J Hepatol. 63:456-61 (2016).

Marschall HU, Wikström Shemer E, Ludvigsson JF, Stephansson O.
Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study.
Hepatology. 58:1385-91 (2013).

 

View: Google Scholar; biometrics
https://scholar.google.se/citations

Complete list of publications

View complete list of publications on PubMed.

Page Manager: Anna Hallén|Last update: 3/10/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?